Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Beran

Showing results (11-20 of 108) with videos related to

Pageof 11
Sort By:
Expert Review of Clinical Pharmacology|March 11, 2020
Spotlight on experiences of medicine unavailability: access to medicines challenges for NCDs and NTDs - the contrasting cases of insulin and praziquantelNadya Wells, François Chappuis, David Beran
The Lancet. Diabetes & Endocrinology|February 10, 2016
Constraints and challenges in access to insulin: a global perspectiveDavid Beran, Margaret Ewen, Richard Laing
BMC Public Health|October 1, 2018
Self-management of diabetes in Sub-Saharan Africa: a systematic reviewVictor Stephani, Daniel Opoku, David Beran
Primary Health Care Research & Development|November 15, 2022
Strategies to address non-communicable diseases in the Commonwealth of Independent States countries: a scoping reviewElvira Muratalieva, Mathieu Nendaz, David Beran
Global Health Action|October 2, 2019
Noncommunicable diseases, access to essential medicines and universal health coverageDavid Beran, Hanne Bak Pedersen, Jane Robertson
BMC Health Services Research|March 1, 2006
Assessing health systems for type 1 diabetes in sub-Saharan Africa: developing a 'Rapid Assessment Protocol for Insulin Access'David Beran, John S Yudkin, Maximilian de Courten
BMJ Global Health|October 1, 2019
Insulin price components: case studies in six low/middle-income countriesDouglas Ball, Margaret Ewen, Richard Laing, et al.
Diabetes Care|August 27, 2005
Access to care for patients with insulin-requiring diabetes in developing countries: case studies of Mozambique and ZambiaDavid Beran, John S Yudkin, Maximilian de Courten
The Lancet. Diabetes & Endocrinology|May 15, 2026
Type 1 diabetes intervention clusters in resource-limited settings: a systematic review and economic evaluationSanjay Basu, Jessica Hanae Zafra-Tanaka, David Beran
Diabetes Care|May 23, 2018
Why Are We Failing to Address the Issue of Access to Insulin? A National and Global PerspectiveDavid Beran, Irl B Hirsch, John S Yudkin
Pageof 11

Showing results (11-20 of 108) with videos related to

Sort By:
Pageof 11
Expert Review of Clinical Pharmacology|March 11, 2020
Spotlight on experiences of medicine unavailability: access to medicines challenges for NCDs and NTDs - the contrasting cases of insulin and praziquantelNadya Wells, François Chappuis, David Beran
The Lancet. Diabetes & Endocrinology|February 10, 2016
Constraints and challenges in access to insulin: a global perspectiveDavid Beran, Margaret Ewen, Richard Laing
BMC Public Health|October 1, 2018
Self-management of diabetes in Sub-Saharan Africa: a systematic reviewVictor Stephani, Daniel Opoku, David Beran
Primary Health Care Research & Development|November 15, 2022
Strategies to address non-communicable diseases in the Commonwealth of Independent States countries: a scoping reviewElvira Muratalieva, Mathieu Nendaz, David Beran
Global Health Action|October 2, 2019
Noncommunicable diseases, access to essential medicines and universal health coverageDavid Beran, Hanne Bak Pedersen, Jane Robertson
BMC Health Services Research|March 1, 2006
Assessing health systems for type 1 diabetes in sub-Saharan Africa: developing a 'Rapid Assessment Protocol for Insulin Access'David Beran, John S Yudkin, Maximilian de Courten
BMJ Global Health|October 1, 2019
Insulin price components: case studies in six low/middle-income countriesDouglas Ball, Margaret Ewen, Richard Laing, et al.
Diabetes Care|August 27, 2005
Access to care for patients with insulin-requiring diabetes in developing countries: case studies of Mozambique and ZambiaDavid Beran, John S Yudkin, Maximilian de Courten
The Lancet. Diabetes & Endocrinology|May 15, 2026
Type 1 diabetes intervention clusters in resource-limited settings: a systematic review and economic evaluationSanjay Basu, Jessica Hanae Zafra-Tanaka, David Beran
Diabetes Care|May 23, 2018
Why Are We Failing to Address the Issue of Access to Insulin? A National and Global PerspectiveDavid Beran, Irl B Hirsch, John S Yudkin
Pageof 11